Gaudium IVF & Women Health IPO

About the company

Incorporated in 2015, Gaudium IVF and Women Health provide IVF and women health services throughout India. The company has developed its operations across different states through a hub-and-spoke system. It provides multiple fertility treatments, which include IVF, ICSI, IUI and ovulation induction to assist men and women who experience infertility challenges. The organisation provides treatment for multiple health conditions, which include PCOS/PCOD, endometriosis and high-risk pregnancy situations. It also provides multiple services, which include advanced sperm retrieval for male infertility treatment, egg freezing and laparoscopic and hysteroscopic surgeries and genetic testing (PGT) and medical support for surrogacy. The company operates more than 30 locations, which include 7 main centres (hubs) and 28 partner clinics (spokes) through its collaboration with infertility specialists to promote knowledge about IVF and assisted reproductive treatments. Its main centres operate from multiple Indian cities, which include Delhi, Mumbai, Ludhiana, Srinagar, Patna, and Bangalore. The company operates a 15-bed hospital at its Janakpuri centre in Delhi NCR, which specialises in mother and child care. IVF treatments generated the highest revenue share, which reached 68.6% or ₹33.9 crore, while the hospital services generated a smaller revenue share of 2.6% or ₹1.29 crore as of H1FY26. The pharmacy, which contributed 28.85% of revenue, operates through its subsidiary, which delivers medical supplies and products to various locations from its Janakpuri facility. The company also provides treatments to international patients from countries like Canada, the United Kingdom, the United States, Kenya, South Africa, and Oman. The organisation provided medical services to 76 international patients during H1FY26, with the majority of patients coming from the UK, USA and Canada. The company established a collaborative agreement with a London-based partner on May 1 2024. The partner organisation provides IVF consulting services to guide patients while receiving 25% of treatment fees, which result from patient referrals. The company has achieved an embryo transfer success rate of 58.7% during H1FY26. The period of 509 embryo transfers led to 299 successful pregnancies. The company performed 1,824 treatment cycles during H1FY26. The company employed 122 workers throughout its centres as of September 2025, which included doctors and nurses, embryologists and counselors and administrative personnel. The attrition rate was 31% during H1FY26, compared to 63% in FY25 and 51% in both FY24 and FY23. The Indian IVF market size is projected to grow from $1.32 billion in 2024 to $4.54 billion by 2034, with a CAGR of 13.13%. The share of India in the global IVF market is planned to increase from around 4.8% in 2024 to 8.3% by 2034, thus placing it among the top fastest, growing IVF markets worldwide. The business has shown steady operational results, with 3,512 cycles in FY23, 3,711 cycles in FY24, 3,476 cycles in FY25, and 1,824 cycles as of September 30, 2025. The company plans to expand its hub-and-spoke model across India. The plan is for different kinds of IVF, IUI, and embryo transfer at major hub centres, which are located in big cities, while smaller spoke centres will mainly do consultation, basic treatment, and follow-up activities near the patient's home. This plan is to facilitate better access to quality fertility services in the abandoned areas, to keep service standards uniform at all locations, to make medical resources available more efficiently, and to have a strong internal referral network. Now, Gaudium IVF & Women Health Ltd is launching its initial public offering (IPO), which consists of a fresh issue of ₹90 crore and an offer for sale of ₹75 crore. The total issue size of the IPO is ₹165 crore. Its shares will be listed on the NSE and BSE. **How to apply for the Gaudium IVF & Women Health IPO?** If you are interested in this investment opportunity but unsure how to apply for the Gaudium IVF & Women Health IPO, here are the steps that you need to follow. When the public issue opens for subscription, one can follow this step-by-step guide on how to apply for the Gaudium IVF & Women Health IPO on Upstox: - Log in to your Upstox account, using your six-digit PIN - After logging in, click on ‘Discover’ - On the ‘Discover’ tab, you will find the ‘Invest in IPO’ section - Under the Invest in IPO section, look for the ‘Gaudium IVF & Women Health IPO’ tab and click on it - Now fill in all the required information, like ‘bid price’ and ‘lot size’ - Confirm and click on ‘Apply’ - Accept the mandate on your UPI app ### **How to check Gaudium IVF & Women Health IPO Allotment Status? ** When the allotment process is completed, you can check the status of your application on the Upstox app. Share allotment is generally completed on the next working day after an IPO closes. Here’s a step-by-step guide on how to check the Gaudium IVF & Women Health IPO allotment status: - Login to your Upstox account, using your six-digit PIN - After logging in, click on ‘Discover’ - On the ‘Discover’ page, you will find the ‘Invest in IPO’ section - Under the Invest in IPO section, you will find the ‘View all’ option - Once you click on ‘View all’, you will be directed to the ‘IPO’ tab - In the ‘IPO’ tab, click on ‘My applications’ - In ‘My applications’, under the History section, your Gaudium IVF & Women Health IPO allotment status will be mentioned ### **How to pre-apply for the Gaudium IVF & Women Health IPO?** You can pre-apply for the Gaudium IVF & Women Health IPO on Upstox. The pre-application for this IPO, which means the pre-apply open date, usually begins a day before the IPO opens for subscription. Follow these steps to pre-apply for the IPO: - Login to your Upstox account, using your six-digit PIN - After successfully logging in, click on ‘Discover’ - On the Discover tab, you will find the ‘Invest in IPO’ section - Under the Invest in IPO section, look for the ‘Gaudium IVF & Women Health IPO’ tab and click on it - Now fill in all the required information, like ‘bid price’ and ‘lot size’ - Confirm and click on ‘Pre-Apply’ - Accept the mandate on your UPI app

GMP trend (Grey Market Premium by date)

Financial performance (₹ Cr)

IPO Roadmap / Timeline

1. IPO Opens

   Completed
   20 Feb 2026

   Bidding starts for all investor categories

2. IPO Closes

   Completed
   24 Feb 2026

   Last day to place your bid

3. Basis of Allotment

   Completed
   25 Feb 2026

   Share allotment finalised

4. Refund Initiation

   Completed
   25 Feb 2026

   Refunds credited for non-allottees

5. Credit to Demat

   Completed
   26 Feb 2026

   Allotted shares credited to demat account

6. Listing on Exchange

   Completed
   27 Feb 2026

   Shares list on NSE / BSE

Post-close dates are indicative as per SEBI T+3 listing framework and may change per registrar updates.